1-4 of 4
Tea Gogishvili
Close
Sort by
Journal Articles

SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7 + normal lymphocytes

Tea Gogishvili, Sophia Danhof, Sabrina Prommersberger, Julian Rydzek, Martin Schreder, Christian Brede, Hermann Einsele, Michael Hudecek
Journal: Blood
Blood (2017) 130 (26): 2838–2847.
https://doi.org/10.1182/blood-2017-04-778423
Published: 2017
Includes: Supplemental data
Journal Articles

Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab

Clinical Trials & Observations
Estefanía García-Guerrero, Tea Gogishvili, Sophia Danhof, Martin Schreder, Celine Pallaud, Jose Antonio Pérez-Simón, Hermann Einsele, Michael Hudecek
Journal: Blood
Blood (2017) 129 (25): 3386–3388.
https://doi.org/10.1182/blood-2017-03-770776
Published: 2017
Includes: Supplemental data
Journal Articles

Panobinostat Induces Upregulation of CD38 and Augments the Anti-Myeloma Efficacy of Daratumumab in Pre-Clinical Models

Estefania Garcia-Guerrero, Tea Gogishvili, PhD, Sophia Danhof, MD, Martin Schreder, MD, Celine Pallaud, PhD, Thomas Lehmann, PhD, Hermann Einsele, MD, Michael Hudecek, MD
Journal: Blood
Blood (2016) 128 (22): 4481.
https://doi.org/10.1182/blood.V128.22.4481.4481
Published: 2016
Journal Articles

CAR-Engineered T Cells Specific for the Elotuzumab Target SLAMF7 Eliminate Primary Myeloma Cells and Confer Selective Fratricide of SLAMF7+ Normal Lymphocyte Subsets

Sophia Danhof, MD, Tea Gogishvili, PhD, Silvia Koch, Martin Schreder, MD, Stefan Knop, Hermann Einsele, Michael Hudecek, MD
Journal: Blood
Blood (2015) 126 (23): 115.
https://doi.org/10.1182/blood.V126.23.115.115
Published: 2015